IM Cannabis Corp. Board Changes Announced

Ticker: IMCC · Form: 6-K · Filed: 2025-09-16T00:00:00.000Z

Sentiment: neutral

Topics: board-changes, management-transition

TL;DR

IM Cannabis Corp. board shakeup: Arbel & Schinderle out, Yitzhaik & Zamir in as of Sept 15, 2025.

AI Summary

IM Cannabis Corp. announced on September 15, 2025, the resignations of Shmulik Arbel and Brian Schinderle from its Board, Audit Committee, and Compensation Committee. The company appointed Asaf Yitzhaik and Eli Zamir to fill these vacancies on the Board and Audit Committee, with Mr. Zamir also joining the Compensation Committee.

Why It Matters

Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing is a routine update on board member changes and does not involve financial transactions or significant operational news.

Key Players & Entities

FAQ

Who resigned from the IM Cannabis Corp. Board and its committees?

Messrs. Shmulik Arbel and Brian Schinderle resigned from the Company's Board, Audit Committee and Compensation Committee, as applicable, effective September 15, 2025.

Who has been appointed to fill the vacancies on the IM Cannabis Corp. Board?

Messrs. Asaf Yitzhaik and Eli Zamir have been appointed to the Board, effective immediately.

What committees have the newly appointed members joined?

Messrs. Asaf Yitzhaik and Eli Zamir have been appointed as members of the Audit Committee. Mr. Zamir has also been appointed as a member of the Compensation Committee.

What is the exact date the board changes became effective?

The resignations were effective September 15, 2025, and the appointments were effective immediately thereafter.

What type of filing is this for IM Cannabis Corp.?

This is a Form 6-K, Report of Foreign Private Issuer, for the month of September 2025.

From the Filing

0001178913-25-003331.txt : 20250916 0001178913-25-003331.hdr.sgml : 20250916 20250916060717 ACCESSION NUMBER: 0001178913-25-003331 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250916 FILED AS OF DATE: 20250916 DATE AS OF CHANGE: 20250916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 251315773 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533785.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of September 2025 (Report No. 2) .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒  Form 40-F ☐   CONTENTS   Board Changes   Effective September 15, 2025, Messrs. Shmulik Arbel and Brian Schinderle have resigned from the Company’s Board, Audit Committee and Compensation Committee, as applicable.   The Board has appointed Messrs. Asaf Yitzhaik and Eli Zamir to the Board and as members of the Audit Committee, effective immediately, to fill in the vacancies created by the foregoing resignations. In addition, Mr. Zamir has been appointed as a member of the Compensation Committee to replace Mr. Schinderle.   Mr. Yitzhaik is a seasoned businessman with over three decades of experience in retail and real estate. He is the owner of ASI Glasses, a long-established optics and optometry business in Israel, and has extensive real estate holdings in Israel and abroad. Mr. Yitzhaik also serves as a director of several publicly traded companies, including Gix Internet Ltd. (TASE: GIX), Rani Zim Shopping Centers Ltd. (TASE: RANI), Save Foods, Inc. (Nasdaq: SVFD), Plentify Ltd. (CSE: PLNT), Polyrizon Ltd. (Nasdaq: POLY), and Clearmind Medicine Inc. (Nasdaq: CMND).   Mr. Zamir brings extensive expertise in finance, capital markets, and public company governance. He has served as CEO of an underwriting firm, CFO of a public real estate company, and raised significant institutional capital for private equity funds and public offerings. Mr. Zamir has also held directorships at leading companies including Formula Systems, Synopsys Israel, AI Conversation Systems, and NewMed Energy. He currently serves as the CEO of Jeff’s Brands Ltd. (Nasdaq: JFBR) and continues to advise and lead M&A and financing activities in the renewable energy sector in Europe.   The Board has also appointed Mr. Oz Adler, a director of the Company, as the new Chairman of the Board, replacing Mr. Oren Shuster, who will continue to serve as the Company’s Chief Executive Officer and a director.   Messrs. Asaf Yitzhaik and Eli Zamir are not a party to any transactions that are disclosable under Item 7.B of Form 20-F.   On September 16, 2025, the Company issued a press release titled: “IM Cannabis Announces Board Changes and Strategic Decision to Identify Additional Business Opportunities”. A copy of this press release is furnished herewith as Exhibit 99.1.   Strategic Decision to Identify Additional Business Opportunities   As part of its ongoing strategic review, the Company has also made a decision to explore the introd

View on Read The Filing